Bydureon and Retinopathy - a phase IV clinical study of FDA data

Summary:

Retinopathy is reported as a side effect among people who take Bydureon (exenatide synthetic), especially for people who are male, 60+ old, have been taking the drug for 1 - 2 years also take Amlodipine, and have Fluid retention.

The phase IV clinical study analyzes which people have Retinopathy when taking Bydureon. It is created by eHealthMe based on reports of 24,229 people who have side effects when taking Bydureon from the FDA, and is updated regularly.

What is Bydureon?

Bydureon has active ingredients of exenatide synthetic. It is often used in type 2 diabetes. eHealthMe is studying from 24,309 Bydureon users. Check the latest studies of Bydureon.

What is Retinopathy?

Retinopathy (acute damage to the retina of the eye) is found to be associated with 441 drugs and 494 conditions by eHealthMe. Check the latest studies of Retinopathy.

On Jul, 27, 2026

24,229 people reported to have side effects when taking Bydureon.
Among them, 11 people (0.05%) have Retinopathy.

Among these 11 people:

How long have people been on Bydureon when they have Retinopathy? *

What is the gender of people who have Retinopathy when taking Bydureon? *

female: 33.33 %
male: 66.67 %

What is the age of people who have Retinopathy when taking Bydureon? *

What are other drugs people take besides Bydureon? *

What are other side effects people have besides Retinopathy? *

Weight Decreased: 7 people, 63.64%
Dyspnea (difficult or laboured breathing): 6 people, 54.55%
Itching: 6 people, 54.55%
Intervertebral Disc Protrusion (spinal disc protrusion): 6 people, 54.55%
High Blood Cholesterol: 6 people, 54.55%
Herpes Zoster: 6 people, 54.55%
Hepatomegaly (abnormal enlargement of the liver): 6 people, 54.55%
Hepatic Pain (pain in liver): 6 people, 54.55%
Gastrointestinal Disorder (functional problems of gastrointestinal tract): 6 people, 54.55%
Fluid Retention (an abnormal accumulation of fluid in the blood): 6 people, 54.55%

What are the existing conditions these people have? *

Polycythaemia Vera (blood disorder in which the bone marrow makes too many red blood cells): 6 people, 54.55%
Fluid Retention (an abnormal accumulation of fluid in the blood): 6 people, 54.55%
Memory Loss: 4 people, 36.36%
Kidney Stones: 4 people, 36.36%
Depression: 4 people, 36.36%
Blood Uric Acid Increased: 4 people, 36.36%
Neuropathy Peripheral (surface nerve damage): 2 people, 18.18%
Blood Pressure Abnormal: 2 people, 18.18%
Blood Calcium Decreased: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Bydureon and have Retinopathy?

- Check whether Retinopathy is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Bydureon:

Bydureon (24,309 reports)

Retinopathy treatments and more:

Retinopathy (4,577 reports)

Browse all side effects of Bydureon:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Retinopathy:

Retinopathy (441 drugs)

Browse all the conditions that are associated with Retinopathy:

Retinopathy (494 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on exenatide synthetic (the active ingredients of Bydureon) and Bydureon (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.